Cargando…
Treatment of Recurrent or Metastatic Uterine Adenosarcoma
PURPOSE: This study retrospectively evaluated overall survival (OS) by treatment of recurrent or metastatic uterine adenosarcoma including surgery, radiation, chemotherapy, and hormonal therapy and evaluated OS and progression-free survival (PFS) after 1st line systemic chemotherapy. METHODS: 78 pat...
Autores principales: | Nathenson, Michael J., Conley, Anthony P., Lin, Heather, Fleming, Nicole, Ravi, Vinod |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763139/ https://www.ncbi.nlm.nih.gov/pubmed/29445312 http://dx.doi.org/10.1155/2017/4680273 |
Ejemplares similares
-
The immune microenvironment of uterine adenosarcomas
por: Ali, Ali Mohammed Refaat, et al.
Publicado: (2020) -
Superior Vena Cava Syndrome associated with recurrent uterine adenosarcoma
por: Sullivan, Mackenzie W., et al.
Publicado: (2020) -
Submucous uterine adenosarcoma—minimally invasive treatment
por: Krentel, H., et al.
Publicado: (2016) -
Epidemiology of adenosarcoma and the inverse probability of treatment weighting (IPTW) adjusted survival analysis of lymph node dissection in uterine adenosarcoma
por: Hu, Hanjie, et al.
Publicado: (2022) -
Genetic analysis of uterine adenosarcomas and phyllodes tumors of the breast
por: Geyer, Felipe C., et al.
Publicado: (2017)